Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells.

ABSTRACT: Transcriptomic analysis of APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells.

PROVIDER: PRJNA639722 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12022252.fastq.gz	Fastqsanger.gz
	SRR12022253.fastq.gz	Fastqsanger.gz
	SRR12022254.fastq.gz	Fastqsanger.gz
	SRR12022255.fastq.gz	Fastqsanger.gz
	SRR12022256.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells

Project description:APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells

| PRJNA640310 | ENA

Transcriptomic analysis of APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells.

Project description:Transcriptomic analysis of APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells.

| PRJNA640318 | ENA

ATAC-seq in control compared to ZEB1 knock-down MDA-MB-231 cells

Project description:ATAC-seq in control compared to ZEB1 knock-down MDA-MB-231 cells

| PRJEB34081 | ENA

SPARC knock down

Project description:SPARC knock down

| PRJNA327124 | ENA

FGFR3 knock-down

Project description:FGFR3 knock-down

| PRJNA330963 | ENA

Transcriptomic analysis of APC knock down HCEC 1CT cells compared to the wild type HCEC 1CT cells.

Project description:In order to investigate sophisticated events during cancer initiation, we established early colorectal cancer development model. We performed scRNA-seq and analyzed the scRNA-seq dataset. scRNA-seq was conducted at 3- and 7-days after transduction of shRNA targeting APC (shAPC) and scrambled shRNA (shScr) on HCEC 1CT cells.

2020-09-25 | GSE152745 | GEO

RNA Sequencing of ARK2 PAX8 Knock Down Cells

Project description:RNA Sequencing of ARK2 PAX8 Knock Down Cells

| PRJNA1082373 | ENA

Knock down of FTO in cervical cancer cells

Project description:Knock down of FTO in cervical cancer cells

| PRJNA551671 | ENA

mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC

Project description:The goal of this study is to compare mRNA expression profiles among wild type, MBD2 knock down, p66α knock down, and ABA- and APC-treated cells.. All cell lines were maintained in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. For the doxycycline inducible gene expression regulation, each cell lines were incubated in the presence of 1 μg/ml doxycycline for 2 days. For the drug treatment, MDA-MB-231 (LM1) cells were incubated in the presence of 10 μM ABA or APC for 2 days. Total cellular RNAs were extracted using Qiazol reagent. The RNA quality was examined by spectrophotometry, agarose gel electrophoresis (calculating the 18S and 28S rRNA ratio) and an Agilent Technologies 2100 Bioanalyzer (ensuring a RIN value greater than 7). Library was prepared with QuantSeq 3’ mRNA-Seq Library Prep Kit FWD. The constructed libraries were subjected to 75-bp single-end sequencing using an Illumina NextSeq 500 sequencer. Using an optimized data analysis workflow, we mapped to the human genome (build hg19) and identified 25,737 transcripts in these cell lines.

2019-05-03 | GSE130637 | GEO

CRISPR/Cas9 knock down line

Project description:CRISPR/Cas9 knock down line

| PRJNA521684 | ENA